NYU Langone Health’s Division of Rheumatology, part of the Department of Medicine, is one of the leading rheumatology divisions in the country. Under the leadership of Jill P. Buyon, MD, division director, we pursue a tradition of excellence reflected in our tripartite mission of providing outstanding training of clinician–scientists; conducting innovative basic, translational, and clinical research; and offering the latest advances in clinical services.

News From NYU Langone Rheumatology

NIH announces inaugural cohort for the Team Science Leadership Scholars Program in Women’s Health, Autoimmune and Immune-Mediated (AMP–AIM) Diseases. Kelly V. Ruggles, PhD, has been named to the cohort, collaborating with rheumatology faculty Jill P. Buyon, MD, and Jose U. Scher, MD, on their AMP–AIM projects.

Oklahoma Medical Research Foundation (OMRF) Awarded $6.4 Million NIH Grant for Lupus Study. Dr. Jill P. Buyon, MD, is co-investigator on the Autoimmune Drivers and Protectants (ADAPTS) study. She and Peter M. Izmirly, MD, will provide patients from their cohort as well as review and classify OMRF cohorts.

Rebecca Haberman, MD, comments on exercising with psoriatic arthritis over the summer.

Greg Silverman, MD, and Doua Azzouz, PhD discuss new research about certain microbiome germs that might trigger lupus flares. Read more about this research.